Data Knights Acquisition Corp. DKDCW
We take great care to ensure that the data presented and summarized in this overview for Data Knights Acquisition Corp. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in DKDCW
Top Purchases
Top Sells
About DKDCW
Insider Transactions at DKDCW
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 26
2025
|
Kenneth Alleyne Director |
BUY
Grant, award, or other acquisition
|
Direct |
38,219
+50.0%
|
-
|
|
Nov 26
2025
|
Eric Casaburi Director |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+28.94%
|
-
|
|
Nov 26
2025
|
Andrew B Zeinfeld Director |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+10.55%
|
-
|
|
Nov 26
2025
|
Jair Clarke Director |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+24.53%
|
-
|
|
Nov 26
2025
|
Thomas Kosasa Director |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+0.28%
|
-
|
|
Nov 26
2025
|
Sherry Coonse Mc Craw Director |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+44.4%
|
-
|
|
Nov 26
2025
|
Aaron Green Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+2.28%
|
-
|
|
Nov 26
2025
|
Robert Lawrence Golden Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+7.59%
|
-
|
|
Nov 26
2025
|
Jeffrey Yu Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+0.61%
|
-
|
|
Nov 24
2025
|
Aaron Green Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,000,000
+34.66%
|
-
|
|
Nov 24
2025
|
Robert Lawrence Golden Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
333,333
+22.6%
|
-
|
|
Nov 24
2025
|
Jeffrey Yu Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+2.67%
|
-
|
|
Nov 18
2025
|
Aaron Green Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
61,555
-3.3%
|
$61,555
$1.2 P/Share
|
|
Oct 22
2025
|
Aaron Green Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
64,767
-3.36%
|
$129,534
$2.23 P/Share
|
|
Oct 15
2025
|
Eric Casaburi Director |
BUY
Open market or private purchase
|
Direct |
10,000
+13.25%
|
$30,000
$3.05 P/Share
|
|
Sep 25
2025
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
1,250
+0.02%
|
$1,250
$1.03 P/Share
|
|
Sep 24
2025
|
Thomas Kosasa Director |
BUY
Open market or private purchase
|
Direct |
6,000
+0.04%
|
$0
$0.93 P/Share
|
|
Sep 24
2025
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
17,200
+0.24%
|
$17,200
$1.02 P/Share
|
|
Sep 23
2025
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
5,700
+0.08%
|
$0
$0.93 P/Share
|
|
Sep 22
2025
|
Jeffrey Yu Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
400
+0.01%
|
$0
$0.95 P/Share
|
Last 12 Months Summary
Buy / Acquisition
14M
Shares
From
15
Insiders
| Grant, award, or other acquisition | 2.12M shares |
|---|---|
| Conversion of derivative security | 8.03M shares |
| Open market or private purchase | 3.9M shares |
Sell / Disposition
126K
Shares
From
1
Insiders
| Open market or private sale | 126K shares |
|---|